208 related articles for article (PubMed ID: 15493007)
1. 2-deoxy-fluorglucose-positron emission tomography imaging of the brain: current clinical applications with emphasis on the dementias.
Van Heertum RL; Greenstein EA; Tikofsky RS
Semin Nucl Med; 2004 Oct; 34(4):300-12. PubMed ID: 15493007
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?
Weber WA
J Nucl Med; 2007 Oct; 48(10):1580-2. PubMed ID: 17909256
[No Abstract] [Full Text] [Related]
3. Is it time to incorporate quantitative functional imaging data, FDG PET in particular, into the response evaluation criteria in solid tumours?
Basu S; Nair N
Nucl Med Commun; 2006 May; 27(5):413-6. PubMed ID: 16609351
[No Abstract] [Full Text] [Related]
4. Voxel-based classification of FDG PET in dementia using inter-scanner normalization.
Thiele F; Young S; Buchert R; Wenzel F
Neuroimage; 2013 Aug; 77():62-9. PubMed ID: 23541799
[TBL] [Abstract][Full Text] [Related]
5. A plea for the elective inclusion of the brain in routine whole-body FDG PET.
Belhocine T; Weiner SM; Brink I; De Deyn PP; Roland J; Van der Borght T; Flamen P
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):251-6. PubMed ID: 15692807
[No Abstract] [Full Text] [Related]
6. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
Menda Y; Graham MM
Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
[TBL] [Abstract][Full Text] [Related]
7. Quantification in positron emission tomography for research in pharmacology and drug development.
Cunningham VJ; Gunn RN; Matthews JC
Nucl Med Commun; 2004 Jul; 25(7):643-6. PubMed ID: 15208489
[TBL] [Abstract][Full Text] [Related]
8. Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders.
El-Haddad G; Zhuang H; Gupta N; Alavi A
Semin Nucl Med; 2004 Oct; 34(4):313-29. PubMed ID: 15493008
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicine.
Vander Borght T; Laloux P; Maes A; Salmon E; Goethals I; Goldman S;
Acta Neurol Belg; 2001 Dec; 101(4):196-209. PubMed ID: 11851026
[TBL] [Abstract][Full Text] [Related]
10. PET and brain tumor image fusion.
Wong TZ; Turkington TG; Hawk TC; Coleman RE
Cancer J; 2004; 10(4):234-42. PubMed ID: 15383204
[TBL] [Abstract][Full Text] [Related]
11. Quantification in clinical fluorodeoxyglucose positron emission tomography.
Hallett WA
Nucl Med Commun; 2004 Jul; 25(7):647-50. PubMed ID: 15208490
[TBL] [Abstract][Full Text] [Related]
12. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
Shea YF; Ha J; Lee SC; Chu LW
Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography applications in clinical neurology.
Singhal T
Semin Neurol; 2012 Sep; 32(4):421-31. PubMed ID: 23361486
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging (PET) of brain tumors.
Basu S; Alavi A
Neuroimaging Clin N Am; 2009 Nov; 19(4):625-46. PubMed ID: 19959009
[TBL] [Abstract][Full Text] [Related]
15. PET and SPECT in common neuropsychiatric disease.
Tatsch K; Ell PJ
Clin Med (Lond); 2006; 6(3):259-62. PubMed ID: 16826858
[No Abstract] [Full Text] [Related]
16. Top-Down Systematic Approach to Interpretation of FDG-PET for Dementia.
Sawyer DM; Kuo PH
Clin Nucl Med; 2018 Jun; 43(6):e212-e214. PubMed ID: 29659399
[TBL] [Abstract][Full Text] [Related]
17. PET evaluation of lung cancer.
Bunyaviroch T; Coleman RE
J Nucl Med; 2006 Mar; 47(3):451-69. PubMed ID: 16513615
[No Abstract] [Full Text] [Related]
18. Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease.
Pilotto A; Premi E; Paola Caminiti S; Presotto L; Turrone R; Alberici A; Paghera B; Borroni B; Padovani A; Perani D
Neurology; 2018 Mar; 90(12):e1029-e1037. PubMed ID: 29453242
[TBL] [Abstract][Full Text] [Related]
19. Brain PET in suspected dementia: patterns of altered FDG metabolism.
Brown RK; Bohnen NI; Wong KK; Minoshima S; Frey KA
Radiographics; 2014; 34(3):684-701. PubMed ID: 24819789
[TBL] [Abstract][Full Text] [Related]
20. Potential of PET/CT in assessing dementias with emphasis on cerebrovascular disorders.
Borja AJ; Hancin EC; Zhang V; Revheim ME; Alavi A
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2493-2498. PubMed ID: 31982989
[No Abstract] [Full Text] [Related]
[Next] [New Search]
